19 May 2013
Keywords: gsk, expands, vaccines, india, glaxosmithkline, biologicals, group
Article | 17 January 2005
GlaxoSmithKline Biologicals, the GSK group's vaccine unit, is to make India a center for clinical R&D and has scheduled ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 January 2005
17 May 2013
© 2013 thepharmaletter.com